Tuesday, November 27, 2018 2:11:11 PM
Do you know if the company is reaching out to congressmen that had previously voiced support for approving Actipatch and if BIEL is trying to organize political pressure regarding this decision?
Seems like the FDA has a lot to answer for considering they approved a new opiate 1000x stronger than morphine in a rushed and expedited session less than a month ago but can't seem to find the cajonez when approving this side-effect free device.
Wish these 2 examples were printed side by side in the media to illuminate the FDA incompetence in promoting and mismanaging the opioid epidemic.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM